Editorial & Advertiser disclosure

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Finance

Posted By Global Banking and Finance Review

Posted on April 2, 2025

Featured image for article about Finance

(Reuters) -Siemens AG said on Wednesday it will acquire U.S.-based Dotmatics for $5.1 billion from private equity firm Insight Partners to strengthen its Life Sciences portfolio.

Financing for the deal would be primarily carried by share sales of listed companies, including healthcare subsidiary Siemens Healthineers, its finance chief Ralf Thomas said in a statement.

Life Sciences presents a software market opportunity and could expand Siemens' industrial software total addressable market by $11 billion, the statement added.

Last week, the German company closed its second biggest acquisition of engineering software firm Altair for $10.6 billion after selling a $1.5 billion stake in Siemens Healthineers.

"By acquiring Dotmatics, we're strategically strengthening our position in Life Sciences and creating a world-leading AI-powered PLM software portfolio as part of Siemens Xcelerator," CEO Roland Busch said.

Siemens said it expects substantial revenue synergies for medium-term revenue of around $100 million per year, accelerating to over $500 million per year in the long term.

Boston, Massachusetts-based Dotmatics is an R&D scientific software company, which is expected to generate more than $300 million in revenue in 2025, with an adjusted EBITDA margin of above 40%.

(Reporting by Urvi Dugar; Editing by Alan Barona)

Recommended for you

  • Thumbnail for recommended article

  • Thumbnail for recommended article

  • Thumbnail for recommended article

;